JP2009535328A5 - - Google Patents

Download PDF

Info

Publication number
JP2009535328A5
JP2009535328A5 JP2009507631A JP2009507631A JP2009535328A5 JP 2009535328 A5 JP2009535328 A5 JP 2009535328A5 JP 2009507631 A JP2009507631 A JP 2009507631A JP 2009507631 A JP2009507631 A JP 2009507631A JP 2009535328 A5 JP2009535328 A5 JP 2009535328A5
Authority
JP
Japan
Prior art keywords
use according
caused
seq
syndrome
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009507631A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009535328A (ja
JP5323682B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2007/000413 external-priority patent/WO2007126363A2/en
Publication of JP2009535328A publication Critical patent/JP2009535328A/ja
Publication of JP2009535328A5 publication Critical patent/JP2009535328A5/ja
Application granted granted Critical
Publication of JP5323682B2 publication Critical patent/JP5323682B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009507631A 2006-04-27 2007-04-27 コンパートメント症候群の治療における使用のための抗分泌性タンパク質 Active JP5323682B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0600933-6 2006-04-27
SE0600933 2006-04-27
PCT/SE2007/000413 WO2007126363A2 (en) 2006-04-27 2007-04-27 Antisecretory protein for use in the treatment of compartment syndrome

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010245989A Division JP5285043B2 (ja) 2006-04-27 2010-11-02 コンパートメント症候群の治療における使用のための抗分泌性タンパク質

Publications (3)

Publication Number Publication Date
JP2009535328A JP2009535328A (ja) 2009-10-01
JP2009535328A5 true JP2009535328A5 (enExample) 2010-06-17
JP5323682B2 JP5323682B2 (ja) 2013-10-23

Family

ID=38655929

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009507631A Active JP5323682B2 (ja) 2006-04-27 2007-04-27 コンパートメント症候群の治療における使用のための抗分泌性タンパク質
JP2010245989A Active JP5285043B2 (ja) 2006-04-27 2010-11-02 コンパートメント症候群の治療における使用のための抗分泌性タンパク質

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010245989A Active JP5285043B2 (ja) 2006-04-27 2010-11-02 コンパートメント症候群の治療における使用のための抗分泌性タンパク質

Country Status (19)

Country Link
US (2) US8309513B2 (enExample)
EP (2) EP2363140B1 (enExample)
JP (2) JP5323682B2 (enExample)
KR (3) KR101805973B1 (enExample)
CN (3) CN104689299B (enExample)
AT (1) ATE526031T1 (enExample)
AU (1) AU2007244003B2 (enExample)
BR (2) BRPI0710794A2 (enExample)
CA (1) CA2650589C (enExample)
DK (3) DK2037950T3 (enExample)
ES (3) ES2472737T3 (enExample)
IL (1) IL194774A (enExample)
MX (1) MX2008013774A (enExample)
NZ (2) NZ572256A (enExample)
PL (2) PL2040734T3 (enExample)
RU (2) RU2457853C2 (enExample)
SG (1) SG171601A1 (enExample)
WO (1) WO2007126363A2 (enExample)
ZA (2) ZA200809114B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090037992A (ko) 2006-04-27 2009-04-17 란트만넨 아스-팍토르 아베 항분비 단백질의 추가적 의학 용도
SG171602A1 (en) * 2006-04-27 2011-06-29 Lantmaennen As Faktor Ab Use of antisecretory factors for treating intraocular hypertension
PL2040734T3 (pl) 2006-04-27 2012-04-30 Lantmaennen As Faktor Ab Białko przeciwwydzielnicze do zastosowania w leczeniu zespołu przedziału
US9962424B2 (en) 2007-04-27 2018-05-08 Lantmännen As-Faktor Ab Use of antisecretory factors (AF) for optimizing cellular uptake
US8901083B2 (en) 2008-11-25 2014-12-02 Temple University Administration of angiocidin for the treatment of leukemia
JP5820277B2 (ja) * 2009-02-11 2015-11-24 ラントメネン・アーエス−ファクトール・アーベー 細胞取込を最適化するための抗分泌性因子(af)の使用
WO2017009004A1 (en) 2015-07-10 2017-01-19 Lantmännen As-Faktor Ab Process for producing egg yolk with high content of af-16
US11407796B2 (en) 2016-07-18 2022-08-09 Lantmännen As-Faktor Ab Antisecretory factor 17
WO2020002464A1 (en) 2018-06-28 2020-01-02 Lantmännen Medical Ab Antisecretory factor for use in treatment and/or prevention of acute respiratory failure
WO2020065091A1 (en) 2018-09-28 2020-04-02 Lantmännen Functional Foods Ab A consumable product comprising malted wheat
CN112770643A (zh) 2018-09-28 2021-05-07 兰特门内保健食品公司 包含麦芽化脱壳燕麦的可消耗产品
EP4125984A1 (en) 2020-03-26 2023-02-08 Lantmännen Functional Foods AB A consumable product comprising malted cereals for promoting recovery at physical activity
WO2026099453A1 (en) * 2024-11-07 2026-05-15 Lantmännen Medical Ab Af-16 or af-17 for acute treatment of brain oedema in patients with traumatic brain injury

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH682716A5 (de) * 1992-01-13 1993-11-15 Christian Fricker Benzo-Pyrone und/oder Dobesilat-Calcium enthaltende pharmazeutische Zusammensetzung.
US5585401A (en) 1994-12-09 1996-12-17 The Reents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
SE508609C2 (sv) 1995-08-24 1998-10-19 Rural Patent Svenska Ab Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning
SE9604251L (sv) 1996-11-20 1997-12-22 Svenska Lantmaennen Riksfoerbu Födoämne som vid förtäring inducerar antisekretoriska proteiner
SE513496C2 (sv) * 1998-12-17 2000-09-18 Rural Patent Svenska Ab NASP-berikad äggula samt dess användning
US7662169B2 (en) * 2000-09-05 2010-02-16 Wittmann Dietmar H Prosthesis and method for lowering abdominal pressure
GB0322645D0 (en) * 2003-09-26 2003-10-29 Melacure Therapeutics Ab Use of antisecretory factor peptides
KR20090037992A (ko) 2006-04-27 2009-04-17 란트만넨 아스-팍토르 아베 항분비 단백질의 추가적 의학 용도
PL2040734T3 (pl) 2006-04-27 2012-04-30 Lantmaennen As Faktor Ab Białko przeciwwydzielnicze do zastosowania w leczeniu zespołu przedziału
WO2009052478A1 (en) * 2007-10-19 2009-04-23 Trustees Of Boston University Metabolic and cardioprotection by the myokine follistatin-like 1 polypeptide

Similar Documents

Publication Publication Date Title
US7420033B2 (en) Composition of lactoferrin related peptides and uses thereof
RU2008146734A (ru) Новый подход к лечению компартмент-синдрома
MX2012011369A (es) Peptidos y su uso.
KR101734064B1 (ko) 마이시니딘 펩타이드로부터 유래한 신규 항균 펩타이드 및 이의 용도
CA2391539A1 (en) Use of poly(diallylamine) polymers
US9333224B2 (en) Silicate containing compositions and methods of treatment
KR20200130174A (ko) 미생물 유래 핵산 및 이의 용도
JPH11514990A (ja) 2−メルカプトエタノールアミン(2−mea)と類縁アミノチオール化合物および3,5−ジイソプロピルサリチル酸銅(▲ii▼)と類縁化合物の、各種疾患を予防および治療するための使用
US4666893A (en) Methods of inducing resistance to bacterial and viral infections
EP1038530A2 (en) Immunomodulator comprising DNA
MX2014003256A (es) Uso de hidroxamatos de indolilo e indolinilo para tratar insuficiencia cardiaca o lesion neuronal.
JP2009509532A (ja) コンドロイチナーゼabci変異体を用いた組成物およびその使用方法
JPH0653670B2 (ja) 化学療法剤の副作用低減化剤
CN117205188A (zh) 维生素k4在制备治疗黑色素瘤的药物中的应用
JP2002521002A (ja) 枯草菌の培養生菌に基づく生物薬剤、並びに細菌感染、ウイルス感染及び免疫不全症状の治療方法
CA1285226C (en) Compositions containing a 2,4-diamino-pyrimidine and sulphadimidine
CN101850104B (zh) 盐酸克林霉素组合药物
RS58951B1 (sr) Lečenje multiple skleroze
CN116732006B (zh) 副溶血弧菌噬菌体解聚酶及其应用
KR102608336B1 (ko) Pep27 펩타이드로부터 유래한 신규 펩타이드 및 이의 용도
KR102873912B1 (ko) 스트렙토코커스 파라우베리스 특이적 신규한 박테리오파지 jbf22001yu 및 이의 용도
RU2258501C2 (ru) Способ применения этидия бромистого для лечения пироплазмоза лошадей
JP2002265354A (ja) 抗ピロリ菌剤組成物
CN103285381B (zh) 核糖核酸酶和斑蝥素的联用
WO2012070967A1 (ru) Ранозаживляющая, противоожоговая, регенерирующая и противовирусная фармацевтическая композиция для местного применения